Japan Short-read Sequencing Market Size & Outlook
Japan short-read sequencing market, 2018-2030 (US$M)
Related Markets
Japan short-read sequencing market highlights
- The Japan short-read sequencing market generated a revenue of USD 232.4 million in 2023 and is expected to reach USD 861.2 million by 2030.
- The Japan market is expected to grow at a CAGR of 20.6% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Short-read sequencing market data book summary
| Market revenue in 2023 | USD 232.4 million |
| Market revenue in 2030 | USD 861.2 million |
| Growth rate | 20.6% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, Macrogenics Inc, Azenta Inc, PerkinElmer, ProPhase Labs Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 4.1% of the global short-read sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China short-read sequencing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,490.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Short-read Sequencing Market Scope
Short-read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan short-read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to short-read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.26% in 2023. Horizon Databook has segmented the Japan short-read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan ranks among the leading Asian countries in short read sequencing market. Rapid adoption of technological innovations and regulatory environment that supports innovation further influence progress. Moreover, Japan is poised to expand its footprints in the field of precision medicine, especially for cancer.
Furthermore, the country has investments in development of efficient diagnosis & treatment for individual patients. The number of conferences that facilitate interaction of researchers, investors, & government has increased. This is expected to increase biotechnology, and omics research in the region. This, in turn, is projected to drive demand for sequencing workflows over the forecast period.
In addition, the healthcare and clinical research service providers in Japan have been integrating sequencing technologies since the past couple of years and are expected to enhance adoption of short read sequencing workflows in the country.
Reasons to subscribe to Japan short-read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan short-read sequencing market databook
-
Our clientele includes a mix of short-read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan short-read sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Japan short-read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan short-read sequencing market size, by product, 2018-2030 (US$M)
Japan Short-read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
